Skip to main content
. 2019 Oct 22;15(4):228–254. doi: 10.1007/s13181-019-00736-9

Table 34.

Clinical signs–other organ systems

N (%)a
Metabolic
  Elevated anion gap (> 20) 286 (4.1)
  Metabolic acidosis (pH < 7.2) 276 (3.9)
  Hypoglycemia (glucose < 50  mg/dL) 122 (1.7)
  Elevated osmole gap (> 20) 28 (0.4)
  Total 535 (7.6)b
Renal/musculoskeletal
  Acute kidney injury (creatinine > 2.0  mg/dL) 285 (4.0)
  Rhabdomyolysis (CPK > 1000  IU/L) 263 (3.7)
  Total 478 (6.8)b
Hematological
  Coagulopathy (PT > 15  s) 139 (2.0)
  Leukocytosis (WBC > 20  K/μL) 82 (1.2)
  Thrombocytopenia (platelets < 100  K/μL) 80 (1.1)
  Hemolysis (Hgb < 10  g/dL) 47 (0.7)
  Methemoglobinemia (MetHgb ≥ 2%) 23 (0.3)
  Pancytopenia 7 (0.1)
  Total 310 (4.4)b
Gastrointestinal/hepatic
  Hepatotoxicity (AST ≥ 1000  IU/L) 220 (3.1)
  Gastrointestinal bleeding 40 (0.6)
  Pancreatitis 29 (0.4)
  Corrosive injury 24 (0.3)
  Intestinal ischemia 4 (0.1)
  Total 294 (4.2)b
Dermatological
  Rash 100 (1.4)
  Blister/Bullae 75 (1.1)
  Angioedema 31 (0.4)
  Necrosis 20 (0.3)
  Total 193 (2.7)b

AST aspartate aminotransferase, PT prothrombin time, WBC white blood cells, Hgb hemoglobin, CPK creatine phosphokinase

aPercentage equals the number of cases reporting specific clinical signs compared to the total number of Registry cases in 2018 (N = 7043)

bTotal reflects cases reporting at least one sign in the category. Cases may be associated with more than one symptom